D-0129-2026 Class II Ongoing
FDA drug recall D-0129-2026 was initiated by FARMAKEIO OUTSOURCING LLC on Oct 14, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 14,329 pellets.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 5, 2025
- Initiation Date
- Oct 14, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,329 pellets
Product description
Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0402-01
Reason for recall
CGMP Deviations: Potential presence of metal particulate matter
Distribution pattern
Nationwide in the USA and Antigua
Code information
Lot, expiry: 3201, Exp 2/7/2026; 3202, Exp 2/21/2026; 3280, Exp 4/8/2026; 3283, Exp /9/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0129-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026